SZL-P1 41 is identified to physically bind to Skp2, thus preventing Skp2 SCF complex formation and inhibiting Skp2 E3 ligase activity, suppressing cancer cells' survival both in vitro and in vivo35. Here, SKP2 is linked to cancer.